Bond Teva Pharma Industries 4.75% ( US88167AAP66 ) in USD
| Issuer | Teva Pharma Industries |
| Market price | |
| Country | Israel
|
| ISIN code |
US88167AAP66 ( in USD )
|
| Interest rate | 4.75% per year ( payment 2 times a year) |
| Maturity | 08/05/2027 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | / |
| Total amount | / |
| Cusip | 88167AAP6 |
| Standard & Poor's ( S&P ) rating | BB ( Non-investment grade speculative ) |
| Moody's rating | Ba1 ( Non-investment grade speculative ) |
| Next Coupon | 09/05/2026 ( In 165 days ) |
| Detailed description |
Teva Pharmaceutical Industries is a global pharmaceutical company specializing in generic and specialty medications, with a focus on central nervous system disorders, respiratory diseases, oncology, and women's health. The Bond issued by Teva Pharma Industries ( Israel ) , in USD, with the ISIN code US88167AAP66, pays a coupon of 4.75% per year. The coupons are paid 2 times per year and the Bond maturity is 08/05/2027 The Bond issued by Teva Pharma Industries ( Israel ) , in USD, with the ISIN code US88167AAP66, was rated Ba1 ( Non-investment grade speculative ) by Moody's credit rating agency. The Bond issued by Teva Pharma Industries ( Israel ) , in USD, with the ISIN code US88167AAP66, was rated BB ( Non-investment grade speculative ) by Standard & Poor's ( S&P ) credit rating agency. |
Français
Italiano
Israel